Docetaxel as Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer
Abstract
Am J Cancer 2006; 5 (3): 207-209 GUEST COMMENTARIES 1175-6357/06/0003-0207/$39.95/0 © 2006 Adis Data Information BV. All rights reserved. conventional anthracycline-containing regimens. Both taxanes are Docetaxel as Neoadjuvant Therapy in Early- now recommended for standard preoperative systemic treatment in Stage or Locally Advanced Breast Cancer many countries, because the above-mentioned aims can be effec- A Viewpoint by Gunter von Minckwitz tively achieved, despite an increase in...